Concerns over the Accessibility of Nicotine E-cigarettes in Queensland, Australia

Aug.18.2022
Concerns over the Accessibility of Nicotine E-cigarettes in Queensland, Australia
Ease of purchasing nicotine e-cigarettes in Queensland, Australia raises concerns over enforcement of regulations. Doctors warn against targeting non-smokers, especially youths.

The accessibility of nicotine e-cigarettes in Queensland, Australia has become a matter of concern. According to the American Medical Association, since October, Australians must have a prescription to legally obtain e-cigarettes containing nicotine, but the regulatory measures have not been effectively enforced. Doctors have expressed that these products are "clearly" targeted towards non-smokers, specifically youth and young adults.


According to a doctor, electronic cigarette products are "clearly" targeted towards non-smokers (image source: AP). Maria Bolton, the president of the Queensland Medical Association, stated that tobacco companies promote e-cigarettes as a smoking cessation aid, but currently liquid nicotine e-cigarette products are not approved for use in Australia.


According to the American Medical Association, despite nearly 84% of individuals never having smoked, over 20% of 18-24 year olds have used e-cigarettes in the 2020-21 year. State government data reveals that approximately 16% of Queensland high school students have reported using e-cigarettes.


Dr. Boulton stated that many teenagers believe that the dangers of vaping are lower than smoking, but it can lead to addiction and inhaling heated gases has been proven to be harmful to the lungs.


Queensland's failure to enforce these laws means that these products are easily accessible, including some that are falsely labeled as "nicotine-free" and others that contain 50 times more nicotine than cigarettes.


A young woman living in the Brisbane city center reported that local suppliers have nicotine e-cigarettes available at their counters, and they will even offer discounts if you pay in cash. When she attempted to purchase non-nicotine e-cigarettes, she was told that the nicotine products were better. Another Brisbane resident suggested asking about available flavors and mentioning that you will pay in cash in order to purchase nicotine e-cigarettes. A woman from the Sunshine Coast claimed that "gift shops" sell e-cigarettes and nicotine versions are typically easy to obtain. However, she also noted that some legitimate vendors, usually tobacco retailers, do not easily sell nicotine products and require identification.


The American Medical Association has written to the Health Minister and Attorney General, urging them to "urgently correct these mistakes before the children of Queensland become the next generation of smokers and suffer the associated catastrophic health consequences".


Dr. Boulton is calling on the government to take action on a series of proposed legal reforms in its tobacco law reform discussion paper, including banning smoking in outdoor markets and school parking lots, disallowing children from smoking in bars and clubs, and requiring tobacco retailers to obtain licenses.


Queensland Health Minister Yvette D'Ath has announced that measures to crack down on the illegal tobacco industry are being considered as part of Queensland's smoking law reforms. In a statement released in May, she expressed the goal of granting authorities additional enforcement powers to combat the illegal tobacco trade.


Statement


This article is compiled from third-party information and is intended for industry professionals for exchange and learning purposes.


This article does not represent the viewpoint of 2FIRSTS, and 2FIRSTS cannot confirm the authenticity or accuracy of the content. The translation of this article is solely for industry communication and research purposes.


Due to limitations in translation abilities, the translated article may not fully express the same meaning as the original. Please refer to the original article for accuracy.


2FIRSTS completely aligns its statements and positions with the Chinese government on all domestic, Hong Kong, Macau, Taiwan, and foreign affairs.


The copyright of the compiled information belongs to the original media and author. If there is any infringement, please contact us for deletion.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Product | FOGER Introduces Switch Pro 30K Nixodine Pod in U.S. Retail, Bringing 6-MN Related Formulation to High-Capacity Pod Platform
Product | FOGER Introduces Switch Pro 30K Nixodine Pod in U.S. Retail, Bringing 6-MN Related Formulation to High-Capacity Pod Platform
FOGER has introduced the Switch Pro 30K Nixodine Pod in U.S. retail channels, bringing a 6-methylnicotine (6-MN)-related formulation into its reusable Switch Pro 30K pod ecosystem. The product retains the existing reusable dock and magnetic replacement pod architecture, featuring a 19ml prefilled pod, dual-mesh heating and Normal/Boost modes. The Nixodine version is labeled nicotine-free in terms of conventional nicotine but uses a 5% Nixodine-related formulation. The product has appeared in U.S. retail and wholesale channels, with some listings indicating Kentucky-only availability.
Aug.28
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Eleftheria (Ria) Kioupritzi, a biopharmaceutical professional with more than 15 years of experience, has joined Philip Morris International as Director Scientific Affairs within Corporate Affairs. She previously served at Roche as Senior Scientific Communications Director for Neuroscience and Rare Diseases and worked extensively in spinal muscular atrophy. Her earlier career also covered competitive intelligence, clinical and regulatory monitoring, pipeline development and launch preparation. During her time working in Roche's SMA field, Evrysdi passed through several U.S. FDA milestones, including its initial approval, an expanded indication for younger infants and approval of a tablet formulation. Public records do not show that Kioupritzi herself led the FDA submissions.
Sep.22
2Firsts Compliance Solutions Hosts PMTA Briefing on FDA Review Signals After JUUL2 Authorization
2Firsts Compliance Solutions Hosts PMTA Briefing on FDA Review Signals After JUUL2 Authorization
Following recent FDA authorizations for JUUL2 and ZYN ULTRA, 2Firsts Compliance Solutions held an online PMTA briefing on Sept. 4 to examine what the decisions may signal about review efficiency, scientific evidence and U.S. market access. Nearly 30 participants from brands, manufacturers, compliance service providers and investment firms joined the discussion.
2Firsts Events
Sep.06
Swedish-Founded Nicotine Pouch Retailer GotPouches Shifts to U.S.-Based Operations, Reaching Over 25 States
Swedish-Founded Nicotine Pouch Retailer GotPouches Shifts to U.S.-Based Operations, Reaching Over 25 States
Swedish-founded online nicotine pouch retailer GotPouches has completed the localization of its U.S. operations under UpNorth Retail LLC, with corporate operations in Franklin, Tennessee, domestic fulfillment from Nashville and U.S.-based customer support. The company says its catalog covers more than 20 nicotine pouch brands and it currently serves customers in more than 25 U.S. states.
Sep.18
Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Nicotine analogues such as 6-methylnicotine are already appearing in e-cigarettes and oral pouches, even as key human evidence remains limited. A new Nixodine-S study adds nonclinical data showing differences from nicotine in cytotoxicity and receptor activity, while independent studies point to a more complex toxicological picture. With supply-chain activity growing and FDA seeking clearer authority over nicotine analogues, the industry now faces a larger question: what evidence is needed before these substances can credibly replace nicotine?
SCIENCE
Sep.23
NATO Executive Director David Spross Sees U.S. Vape Regulation Improving, Calls for More PMTA Authorizations and Warns of 2027 State Tax Pressure
NATO Executive Director David Spross Sees U.S. Vape Regulation Improving, Calls for More PMTA Authorizations and Warns of 2027 State Tax Pressure
The National Association of Tobacco Outlets is calling for more FDA marketing authorizations, greater transparency in the PMTA process and continued enforcement against unauthorized e-cigarettes, even as its executive director, David Spross, points to recent regulatory developments as signs of progress. At the state level, excise taxes, flavor restrictions and vapor product directories remain major issues for tobacco retailers. By August 2026, 17 states had enacted laws establishing state-managed e-cigarette directories or similar systems.
Innovation
Sep.29 by 2Firsts Perspectives